Discovery of direct inhibitor of KRAS oncogenic protein by natural products: a combination of pharmacophore search, molecular docking, and molecular dynamic studies

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

HASHEMI SAMANEH; Sharifi Amirhossein; Zareei Sara; Mohamedi Ghazale; BIGLAR MAHMOOD; AMANLOU MASOUD

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: RESEARCH IN PHARMACEUTICAL SCIENCES (RPS) Year:2020 | Volume:15 | Issue:3 Page(s): 226-240

Download Full-Text

View:

185

Download:

Cites:

Information Journal Paper

Title

Discovery of direct inhibitor of KRAS oncogenic protein by natural products: a combination of pharmacophore search, molecular docking, and molecular dynamic studies

Author(s)

Keywords

Auriculasin

Docking studies

Flavonoid

KRAS

Molecular dynamic simulations

Virtual Screening

Abstract

Background and purpose: Aberrant signaling by oncogenic RAS proteins occurs in almost all human tumors. One of the promising strategies to overcome such cancers is the inhibition of KRAS protein, a subtype of RAS family involved in cell growth, differentiation, and apoptosis, through preventing its effector, SOS1, from being attached to the protein. Experimntal approach: Herein, a Virtual Screening process was performed using pharmacophore search, molecular docking, and Molecular dynamic simulations. A pharmacophore model was created to indicate essential features for a KRAS inhibitor and used for screening the National Cancer Institution (NCI) database to retrieve similar compounds to the pharmacophore model with more than 70% similarity. Chosen compounds were then docked into KRAS and four compounds were selected based on the highest binding scores. Next, a similarity search was done in the whole PubChem database to increase the number of potential inhibitors. The filtered compounds were docked again into KRAS and three of them were selected for molecular dynamic simulation. Findings / Results: Compounds 1a, 2d, and 3a can inhibit SOS-iKRASG12D interaction due to the higher number of interactions with the protein. Moreover, they achieved the equilibrium faster than the approved inhibitor. Conclusion and implications: Auriculasin, a polyphenol Flavonoid, can be considered as a potential inhibitor of SOS1-KRAS interaction. This compound seems to be a stronger anticancer than 9LI, a known inhibitor of KRAS, due to its better docking scores. Moreover, this compound can be an appropriate candidate to be formulated as an oral drug.

Multimedia

No record.

Cites

No record.

References

No record.

Cite

APA: Copy

HASHEMI, SAMANEH, Sharifi, Amirhossein, Zareei, Sara, Mohamedi, Ghazale, & BIGLAR, MAHMOOD. (2020). Discovery of direct inhibitor of KRAS oncogenic protein by natural products: a combination of pharmacophore search, molecular docking, and molecular dynamic studies. RESEARCH IN PHARMACEUTICAL SCIENCES (RPS), 15(3), 226-240. SID. https://sid.ir/paper/318511/en

Vancouver: Copy

HASHEMI SAMANEH, Sharifi Amirhossein, Zareei Sara, Mohamedi Ghazale, BIGLAR MAHMOOD. Discovery of direct inhibitor of KRAS oncogenic protein by natural products: a combination of pharmacophore search, molecular docking, and molecular dynamic studies. RESEARCH IN PHARMACEUTICAL SCIENCES (RPS)[Internet]. 2020;15(3):226-240. Available from: https://sid.ir/paper/318511/en

IEEE: Copy

SAMANEH HASHEMI, Amirhossein Sharifi, Sara Zareei, Ghazale Mohamedi, and MAHMOOD BIGLAR, “Discovery of direct inhibitor of KRAS oncogenic protein by natural products: a combination of pharmacophore search, molecular docking, and molecular dynamic studies,” RESEARCH IN PHARMACEUTICAL SCIENCES (RPS), vol. 15, no. 3, pp. 226–240, 2020, [Online]. Available: https://sid.ir/paper/318511/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops